Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Support Care Cancer ; 29(9): 5435-5445, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33704565

RESUMEN

PURPOSE: Breast cancer-related lymphedema (BCRL) is a major long-term complication for post-surgery breast cancer survivors. Although several risk factors have been identified, lifestyle characteristics have been neglected in previous studies. The aim of this study was to develop and validate a nomogram for estimating this population's risk of developing lymphedema, taking into consideration their demographic, clinical, and personal lifestyle behaviors. METHODS: In a cross-sectional study, we collected data from 775 post-operative breast cancer survivors who had attended a follow-up session in the recent 10 years (primary cohort). Lymphedema was assessed using the Norman telephone questionnaire, self-reported by patients. Multiple logistic regression was used to identify risk factors for lymphedema, including demographic, clinical, and lifestyle-related factors. A nomogram was constructed based on those factors and was validated using a separate group of 314 breast cancer patients (validation cohort). RESULTS: The factors independently associated with lymphedema were higher body mass index (BMI), modified radical mastectomy (MRM), postsurgical infection, chemotherapy, radiotherapy, exercise of the affected arm, and the active participation in physical activity (P<0.05). The area under the curve (AUC) values of the primary and the validation cohorts were 0.721 (95% confidence interval: 0.685-0.756) and 0.702 (95% confidence interval: 0.646-0.759), respectively. CONCLUSIONS: BCRL risk factors include MRM, radiotherapy, chemotherapy, and higher BMI, while the active physical activity behavior of patients appears to be a factor against lymphedema. The nomogram incorporating the patients' clinical and lifestyle factors might be useful for predicting lymphedema in breast cancer survivors.


Asunto(s)
Linfedema del Cáncer de Mama , Neoplasias de la Mama , Supervivientes de Cáncer , Linfedema , Linfedema del Cáncer de Mama/epidemiología , Linfedema del Cáncer de Mama/etiología , Neoplasias de la Mama/cirugía , China , Estudios Transversales , Femenino , Humanos , Linfedema/epidemiología , Linfedema/etiología , Mastectomía , Nomogramas
2.
Eur J Cancer Care (Engl) ; 29(5): e13259, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32424878

RESUMEN

OBJECTIVE: We investigated the effects of mindfulness-based cognitive therapy on insomnia (MBCT-I) in breast cancer survivors. METHODS: In total, 136 participants were allocated randomly to a MBCT-I group or a waitlist control (WLC) group. Indicators of insomnia and mindfulness were evaluated using the Insomnia Severity Index, actigraphy and the Five Facet Mindfulness Questionnaire. Data were collected at baseline (T1), post-intervention (T2), 3-month follow-up (T3) and 6-month follow-up (T4) time points. RESULTS: Insomnia severity decreased significantly in the MBCT-I group, compared with the WLC group, at T2, T3 and T4 (all p < .001). We found that 59.6% of the MBCT-I group with moderate and severe insomnia improved to no insomnia and subclinical insomnia at T4 relative to T1, accounting for 7.9% and 55.3%, respectively. Compared with the WLC group, the MBCT-I group improved on actigraphy measures of sleep; they exhibited a pattern of decreased sleep onset latency and waking after sleep onset, as well as increased total sleep time and sleep efficiency. Mindfulness also increased more in the MBCT-I group than in the WLC group at T2, T3 and T4 (all p < .001). CONCLUSIONS: MBCT-I may be an efficacious non-pharmacologic intervention to improve sleep quality in breast cancer survivors.


Asunto(s)
Neoplasias de la Mama , Supervivientes de Cáncer , Terapia Cognitivo-Conductual , Atención Plena , Trastornos del Inicio y del Mantenimiento del Sueño , Neoplasias de la Mama/terapia , Femenino , Humanos , Trastornos del Inicio y del Mantenimiento del Sueño/terapia , Resultado del Tratamiento
3.
Phytochem Anal ; 31(3): 384-394, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31880044

RESUMEN

INTRODUCTION: Alismatis Rhizoma (AR) has been widely used to treat various diseases. Its complex chemical composition has caused certain difficulties in the analysis of this traditional Chinese medicine. Therefore, it is necessary to establish a method for the rapid classification and identification of the chemical constituents of AR. OBJECTIVE: This article describes a method for the rapid classification and identification of major triterpenoids in AR. METHODOLOGY: The samples were analysed by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). The assay was performed on a Waters ACQUITY UPLC BEH C18 column (100 mm × 2.1 mm, 1.7 µm) with 0.1% formic acid in water (A), and acetonitrile (B) as mobile phase by gradient elution at a flow rate of 0.3 mL/min. In the positive ion mode, the fragment information was obtained and compared with the characteristic fragments and neutral losses described in the literature. Then, the rapid classification and identification of the chemical components from AR were achieved. RESULTS: Finally, 25 triterpene compounds of AR were identified. CONCLUSIONS: The method established in this study achieved the rapid classification and identification of chemical components in AR, which promotes the development of research methods to study the constituents of traditional Chinese medicine.


Asunto(s)
Alisma , Medicamentos Herbarios Chinos , Triterpenos , Cromatografía Líquida de Alta Presión , Espectrometría de Masas en Tándem
4.
Zhongguo Zhong Yao Za Zhi ; 43(4): 676-683, 2018 Feb.
Artículo en Zh | MEDLINE | ID: mdl-29600640

RESUMEN

ABC efflux proteins are a kind of transporters mediating diversified endogenous and exogenous efflux protein substrates across the plasma membrane by depending on the chemical energy released by ATP hydrolysis. As a vitally important functional membrane, it is widely found in various tissues and organs. The drug changes the expressions and/or functions of the transport proteins, which will affect the disposal process of substrate drugs corresponding to transporters in vivo, and finally lead to the pharmacokinetic interactions. The efflux proteins take part in the absorption, distribution, metabolism and excretion of drugs, and mainly consist of P-glycoprotein(P-gp), multidrug resistance associated protein(MRP) and breast cancer resistance protein(BCRP). The induction effect or inhibition effect of drugs on efflux protein plays a greatly significant role in the drug interaction produced by the compatibility of traditional Chinese medicine, which may be one of the important mechanisms of the theory of seven features of compatibility. In this article, the effects of seven features of compatibility on the ABC efflux transporters were reviewed, in order to reveal the roles of efflux protein in the herb-pairs compatibility, and provide new ideas for the mechanism and rationality of herb compatibility.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Medicina Tradicional China , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/metabolismo , Preparaciones de Plantas/farmacología , Interacciones Farmacológicas , Humanos
5.
AAPS PharmSciTech ; 12(2): 705-11, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21637946

RESUMEN

Berberine chloride (BBR) is a natural isoquinoline alkaloid extracted from medicinal herbs. It has been reported that the intestinal absorption of BBR is very low. In this study, the absolute bioavailability of BBR was studied, and the enhancing effects of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on intestinal absorption were investigated in rats. BBR injection was administrated via the femoral vein at a dose of 1.0 mg kg(-1) in intravenous group, and BBR oral formulations were administrated by oral gavage at a dose of 100 mg kg(-1) in BBR control (control) group and BBR-TPGS (test) group, respectively. The result showed that BBR had a very low absolute bioavailability of 0.68%, and TPGS could enhance intestinal absorption of BBR significantly. TPGS at a concentration of 2.5% could improve peak concentration (C(max)) and area under the curve (AUC(0-36)) of BBR by 2.9 and 1.9 times, respectively. The absorption enhancing ability of TPGS may be due to its ability to affect the biological activity of P-glycoprotein and thereby reduce the excretion of absorbed BBR into the intestinal lumen. This study indicated that absolute bioavailability of BBR was 0.68% in rats, and TPGS was a good absorption enhancer capable of enhancing intestinal absorption of BBR significantly.


Asunto(s)
Berberina/farmacocinética , Portadores de Fármacos/farmacocinética , Absorción Intestinal/fisiología , Vitamina E/análogos & derivados , Administración Oral , Animales , Berberina/administración & dosificación , Berberina/normas , Disponibilidad Biológica , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/normas , Sinergismo Farmacológico , Absorción Intestinal/efectos de los fármacos , Masculino , Polietilenglicoles/administración & dosificación , Polietilenglicoles/farmacocinética , Polietilenglicoles/normas , Distribución Aleatoria , Ratas , Ratas Wistar , Vitamina E/administración & dosificación , Vitamina E/farmacocinética , Vitamina E/normas
6.
Eur J Oncol Nurs ; 51: 101909, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33626424

RESUMEN

PURPOSE: Breast cancer (BC) survivors have a lifelong risk of developing lymphedema. This study investigated the prevalence of BC-related arm lymphedema among Chinese BC survivors diagnosed in the last 10 years and examined the demographic and clinical variables as well as lifestyle factors associated with lymphedema status. METHODS: In this cross-sectional study, women with BC (N = 866) who had been diagnosed and followed up in the previous 10 years were recruited from the outpatient clinic of 4 general hospitals and one cancer association in China between August 2018 and October 2019. Lymphedema status was determined using the Norman telephone questionnaire as the patient-reported occurrence of hand/lower arm/upper arm swelling. Multiple logistic regression was used to identify risk factors for lymphedema. RESULTS: The median time from BC diagnosis was 4.0 years (interquartile range, 2.0-5.0 years). 81.4% of the patients had undergone mastectomy. The prevalence of arm lymphedema among BC survivors was 49.0%. Age ≥50 years, monthly income <3000 RMB, modified radical mastectomy, postsurgical wound infection, chemotherapy, and radiotherapy were associated with an increased risk of BC-related arm lymphedema, whereas exercise of the affected arm, engagement in active physical activity, and timely reporting of symptoms of infection to a physician decreased the risk (P < 0.05). CONCLUSIONS: Arm lymphedema is a common complication for postoperative BC survivors within 10 years. It is essential to identify patients at risk of lymphedema based on demographic, clinical, and lifestyle factors and implement interventions targeting modifiable lifestyle behaviors-eg, active physical activity during the postoperative period.


Asunto(s)
Linfedema del Cáncer de Mama/epidemiología , Neoplasias de la Mama/complicaciones , Supervivientes de Cáncer/estadística & datos numéricos , Adulto , Brazo , Neoplasias de la Mama/cirugía , China/epidemiología , Estudios Transversales , Femenino , Humanos , Persona de Mediana Edad , Periodo Posoperatorio , Prevalencia , Factores de Riesgo , Encuestas y Cuestionarios
7.
Biomed Pharmacother ; 132: 110835, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33035828

RESUMEN

Bile acids has gradually become a new focus in various diseases, and ASBT as a transporter responsible for the reabsorption of ileal bile acids, is a key hinge associated to the bile acids-cholesterol balance and bile acids of enterohepatic circulation. The cumulative studies have also shown that ASBT is a promising target for treatment of liver, gallbladder, intestinal and metabolic diseases. This article briefly reviewed the process of bile acids enterohepatic circulation, as well as the regulations of ASBT expression, covering transcription factors, nuclear receptors and gut microbiota. In addition, the relationship between ASBT and various diseases were discussed in this paper. According to the structural classification of ASBT inhibitors, the research status of ASBT inhibitors and potential ASBT inhibitors of traditional Chinese medicine (such resveratrol, jatrorrhizine in Coptis chinensis) were summarized. This review provides a basis for the development of ASBT inhibitors and the treatment strategy of related diseases.


Asunto(s)
Ácidos y Sales Biliares/metabolismo , Colesterol/metabolismo , Transportadores de Anión Orgánico Sodio-Dependiente/antagonistas & inhibidores , Simportadores/antagonistas & inhibidores , Animales , Desarrollo de Medicamentos , Descubrimiento de Drogas/métodos , Humanos , Íleon/metabolismo , Medicina Tradicional China , Transportadores de Anión Orgánico Sodio-Dependiente/metabolismo , Simportadores/metabolismo
8.
Yao Xue Xue Bao ; 43(5): 509-12, 2008 May.
Artículo en Zh | MEDLINE | ID: mdl-18717339

RESUMEN

To study the C21 steroids of the stems of Marsdenia tenacissima (Roxb.) Wight et Arn, various chromatography methods were used for the isolation of the constituents and their structures were identified by spectral analysis. Eight C21 steroids were isolated from the CHCl3 extract, which were identified as 11alpha-O-tigloyl-17beta-tenacigenin B (1), 17beta-tenacigenin B (2), tenacigenoside A (3), 11alpha-O-2-methylbutyryl-12beta-O-acetyl tenacigenin B (4), tenacissoside H (5), marsdenoside A (6), tenacissoside G (7), and tenacissoside I (8). Among them, compound 1 is a new compound.


Asunto(s)
Marsdenia/química , Saponinas/aislamiento & purificación , Esteroides/aislamiento & purificación , Estructura Molecular , Tallos de la Planta/química , Plantas Medicinales/química , Saponinas/química , Esteroides/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA